Literature DB >> 9075305

Association of DNA polymorphism in the first intron of the tyrosine hydroxylase gene with disturbances of the catecholaminergic system in schizophrenia.

F Thibaut1, J M Ribeyre, N Dourmap, R Meloni, C Laurent, D Campion, J F Ménard, S Dollfus, J Mallet, M Petit.   

Abstract

We examined whether there are clinical or biological differences in chronic schizophrenic patients sharing a rare variant allele (a perfect ten tetranucleotide repeats allele of the human TH01 microsatellite) in the tyrosine hydroxylase (TH) gene. For that purpose, clinical parameters (PANSS subscores) and plasma measurements (homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol (MHPG)) were analyzed in five schizophrenic patients sharing the rare allele and 19 schizophrenic patients who did not possess this allele. The mean concentration of plasma HVA and plasma MHPG were significantly lower in the group of schizophrenic patients sharing the rare allele. No other group differences were observed between both groups. These results suggest that this TH gene polymorphism may be associated with disturbances of the catecholaminergic pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9075305     DOI: 10.1016/s0920-9964(96)00118-1

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  13 in total

1.  PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment.

Authors:  Eun-Joo Shin; Chu Xuan Duong; Xuan-Khanh Thi Nguyen; Guoying Bing; Jae-Hyung Bach; Dae Hun Park; Keiichi Nakayama; Syed F Ali; Anumantha G Kanthasamy; Jean L Cadet; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2011-06-13       Impact factor: 3.921

Review 2.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 3.  Meta-analysis shows association between the tryptophan hydroxylase (TPH) gene and schizophrenia.

Authors:  Dawei Li; Lin He
Journal:  Hum Genet       Date:  2006-06-02       Impact factor: 4.132

4.  The HumARA genotype is linked to spinal and bulbar muscular dystrophy and some further disease risks and should no longer be used as a DNA marker for forensic purposes.

Authors:  Reinhard Szibor; Sandra Hering; Jeanett Edelmann
Journal:  Int J Legal Med       Date:  2005-02-03       Impact factor: 2.686

Review 5.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

Review 6.  Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines.

Authors:  A Nakashima; N Hayashi; Y S Kaneko; K Mori; E L Sabban; Toshiharu Nagatsu; A Ota
Journal:  J Neural Transm (Vienna)       Date:  2009-04-25       Impact factor: 3.575

7.  Analysis of the mesotelencephalic dopamine system by quantitative-trait locus introgression.

Authors:  C Vadasz; I Sziraki; M Sasvari; P Kabai; L R Murthy; M Saito; I Laszlovszky
Journal:  Neurochem Res       Date:  1998-11       Impact factor: 3.996

8.  Noggin Along with a Self-Assembling Peptide Nanofiber Containing Long Motif of Laminin Induces Tyrosine Hydroxylase Gene Expression.

Authors:  Shima Tavakol; Sayed Mostafa Modaress Musavi; Behnaz Tavakol; Elham Hoveizi; Jafar Ai; Seyed Mahdi Rezayat
Journal:  Mol Neurobiol       Date:  2016-07-08       Impact factor: 5.590

Review 9.  Post-genomic era and gene discovery for psychiatric diseases: there is a new art of the trade? The example of the HUMTH01 microsatellite in the Tyrosine Hydroxylase gene.

Authors:  Rolando Meloni; Nicole Faucon Biguet; Jacques Mallet
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.682

10.  Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Matthew W Rice; Robert R Conley; Rosalinda C Roberts
Journal:  Front Psychiatry       Date:  2012-04-09       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.